Ken Fisher’s Latest Portfolio: 5 Best Picks Under $30

3. GlaxoSmithKline plc. (NYSE:GSK)

Fisher Investments’ Stake Value: $851.8M

Percentage of  Fisher Investments’ 13F Portfolio: 0.6%

Number of Hedge Fund Holdings: 34

Share Price (As of September 15): $29.8

Headquartered in London, GlaxoSmithKline plc. (NYSE:GSK) is a British multinational pharmaceutical and biotechnology company. It is the tenth largest pharmaceutical company in the world by revenue of ranks at #294 on the 2022 Fortune Global 500.

On September 5, Credit Suisse analyst Johanna Walton upgraded GlaxoSmithKline plc. (NYSE:GSK) to Neutral from Underperform, conferring it with a price target of $1633.